Tradestie Institutional Equity Comparison Engine

ECG vs CDNL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ECG Overall Edge

ECG Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Everus Construction Group, Inc. (ECG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ECG trades at 10.8x Forward P/E with 8.2% operating margin (+40.3% YoY revenue) versus CDNL at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ECG sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against CDNL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ECG
ECG 10.8x vs CDNL N/M Fwd P/E
Growth & Margin Winner ECG
Op Margin 8.2% vs N/A ยท YoY +40.3% vs N/A
Momentum & Technical Winner ECG
1Y -9.5% vs -79.6% ยท 52W Pos 6% vs 0%
Options & Structure Winner ECG
BREAKDOWN (6th %ile IV) vs UNCLASSIFIED (N/A IV)
ECG NYSE
Everus Construction Group, Inc.
Operative Builders
$76.59
-8.66% 1D
Market Cap $4.3B
1M Return -21.08%
1Y Return -9.5%
Forward P/E 10.8x
Unified AI Score
50.0 / 100 HOLD
Tech 73.0 Fund 64.0 Flow 55.0 Mom 64.0
CDNL US Equity
CDNL
Institutional Equity
$4.75
-8.4% 1D
Market Cap N/A
1M Return -65.34%
1Y Return -79.57%
Forward P/E N/M
Unified AI Score
44.2 / 100 HOLD
Tech 45.0 Fund 42.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ECG -9.5% CDNL -79.57% Spread: +61.76 pp (ECG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ECG TTM Op. Margin: 8.2% CDNL TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ECG vs CDNL. Trailing 12-month operating profitability (ECG 8.2% vs CDNL N/A) and valuation multiples (ECG 10.8x vs CDNL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ECG (10) vs CDNL (0)
Institutional Metric ECG CDNL Criterion Row Winner
Market Capitalization Scale $4.3B N/A Larger Scale ECG
Trailing P/E Ratio Valuation 15.1x N/M Lower Multiple ECG
Forward P/E Ratio Valuation 10.8x N/M Lower Multiple ECG
Revenue Growth (YoY) Growth +40.3% N/A Higher Growth ECG
Operating Margin (TTM) Profitability 8.2% N/A Higher Margin ECG
Net Profit Margin Profitability 6.2% N/A Higher Margin ECG
Return on Equity (ROE) Capital Efficiency 40.3% N/A Higher ROE ECG
52-Week Range Position Momentum 6% ($70โ€“$172) 0% ($5โ€“$96) Stronger Trend ECG
Beta / 30D Volatility Risk Regime 2.17ฮฒ ยท 127% Vol 2.65ฮฒ ยท 238% Vol Lower Realized Risk ECG
Unified Institutional Score Composite Signal 50.0 / 100 (HOLD) 44.2 / 100 (HOLD) Higher Composite ECG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ECG vs CDNL Buy Guide
ECG BREAKDOWN
138d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ECG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CDNL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDNL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ECG nor CDNL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.